Why Ross Stores Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

Author: Avi Kapoor | May 24, 2024 08:22am

Shares of Ross Stores, Inc. (NASDAQ:ROST) rose sharply in today's pre-market trading after the company reported better-than-expected earnings for its first quarter and increased its profit forecast for the year.

The company posted quarterly revenue of $4.858 billion, versus estimates of $4.833 billion. Earnings came in at $1.46 per share, versus estimates of $1.34 per share, according to data from Benzinga Pro.

Ross Stores shares jumped 8.2% to $142.73 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

Netcapital Inc. (NASDAQ:NCPL) rose 105.2% to $0.3587 in today's pre-market trading after jumping 15% on Thursday.
Akanda Corp. (NASDAQ:AKAN) shares gained 99.2% to $4.76 in pre-market trading after dipping 35% on Thursday.
Cue Health Inc. (NASDAQ:HLTH) gained 36.4% to $0.1288 in pre-market trading after falling around 12% on Thursday. Cue Health, last week, announced that it voluntarily and temporarily paused sales and distribution of its EUA COVID-19 Test Cartridge.
Verastem, Inc. (NASDAQ:VSTM) gained 35.3% to $16.48 in pre-market trading. Verastem Oncology disclosed positive initial interim safety and efficacy results from RAMP 205 trial evaluating avutometinib plus defactinib in combination with gemcitabine and nab-paclitaxel in first-line metastatic pancreatic cancer.
Nuburu, Inc. (NYSE:BURU) shares rose 26.8% to $0.1759 in pre-market trading.
Blue Star Foods Corp. (NASDAQ:BSFC) shares gained 24.8% to $3.13 in pre-market trading. The company, earlier during the week, reported first-quarter financial results.
Candel Therapeutics, Inc. (NASDAQ:CADL) shares climbed 19.2% to $12.74 in pre-market trading. Candel Therapeutics reported prolonged overall survival in Phase 2 clinical trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in patients non-responsive to Immune Checkpoint Inhibitor (ICI) treatment at 2024 ASCO Annual Meeting.
OneMedNet Corporation (NASDAQ:ONMD) gained 17% to $1.72 in pre-market trading. OneMedNet shares jumped 208% on Thursday after the company highlighted a ‘five-fold expansion’ of its iRWD network and platform.
Biora Therapeutics, Inc. (NASDAQ:BIOR) gained 12.3% to $0.5579 in pre-market trading after tumbling 28% on Thursday.

Losers

Soluna Holdings, Inc. (NASDAQ:SLNH) shares declined 43.7% to $1.40 in pre-market trading after dipping 6% on Thursday.
Sensei Biotherapeutics, Inc.. (NASDAQ:SNSE) shares declined 31.5% to $1.00 in pre-market trading. Sensei Biotherapeutics presented clinical data from Phase 1 dose escalation study of SNS-101.
Barnes & Noble Education, Inc. (NYSE:BNED) shares dipped 24.1% to $0.60 in pre-market trading after the company reported preliminary FY24 consolidated revenue of approximately $1.567 billion.
Summit Therapeutics Inc. (NASDAQ:SMMT) shares fell 21.2% to $3.40 in pre-market trading.
Akoustis Technologies, Inc. (NASDAQ:AKTS) shares fell 15.8% to $0.1765 in pre-market trading after dipping 33% on Thursday. Akoustis recently announced a $10 million registered direct offering priced at-the-market under Nasdaq rules.
Pineapple Energy Inc. (NASDAQ:PEGY) shares fell 13.7% to $0.2090 in pre-market trading after jumping 61% on Thursday.
Phoenix Motor Inc (NASDAQ:PEV) shares fell 13% to $0.62 in pre-market trading. Phoenix Motor said it has rescheduled its first quarter 2024 earnings call to Thursday, May 30, at 4:30 p.m. ET.
Roadzen Inc (NASDAQ:RDZN) fell 12.6% to $3.36 in pre-market trading.
Workday, Inc. (NASDAQ:WDAY) shares declined 12.4% to $228.48 in pre-market trading. Workday posted upbeat earnings for its first quarter. However, the company lowered its forward guidance and now sees second-quarter subscription revenue of $1.895 billion and fiscal-year subscription revenue of between $7.7 billion and $7.725 billion.
Intuit Inc. (NASDAQ:INTU) shares fell 6.3% to $620.82 in pre-market trading. Intuit posted better-than-expected earnings for its third quarter and boosted its full-year outlook. However, the company issued weak earnings guidance for the current quarter.